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Abstract
Background: Estimates suggest that approximately 1 in 10 patients admitted to hospital experience an adverse
event resulting in harm. Methods to improve patient safety have concentrated on developing safer systems of care
and promoting changes in professional behaviour. There is a growing international interest in the development of
interventions that promote the role of patients preventing error, but limited evidence of effectiveness of such
interventions. The present study aims to undertake a randomised controlled trial of patient-led teaching of junior
doctors about patient safety.
Methods/Design: A randomised cluster controlled trial will be conducted. The intervention will be incorporated
into the mandatory training of junior doctors training programme on patient safety. The study will be conducted
in the Yorkshire and Humber region in the North of England. Patients who have experienced a safety incident in
the NHS will be recruited. Patients will be identified through National Patient Safety Champions and local Trust
contacts. Patients will receive training and be supported to talk to small groups of trainees about their experiences.
The primary aim of the patient-led teaching module is to increase the awareness of patient safety issues amongst
doctors, allow reflection on their own attitudes towards safety and promote an optimal culture among the doctors
to improve safety in practice. A mixture of qualitative and quantitative methods will be used to evaluate the
impact of the intervention, using the Attitudes to Patient Safety Questionnaire (APSQ) as our primary quantitative
outcome, as well as focus groups and semi-structured interviews.
Discussion: The research team face a number of challenges in developing the intervention, including integrating a
new method of teaching into an existing curriculum, facilitating effective patient involvement and identifying
suitable outcome measures.
Trial Registration: Current controlled Trials: ISRCTN94241579
Background
Patient safety is an international health priority [1]. Esti-
mates suggest that approximately 1 in 10 patients
admitted to National Health Services hospitals in the
UK is involved in an incident which results in harm to
patients [2] with a subsequent cost to the NHS of over
£2 billion [3]. Strategies to reduce patient safety inci-
dents have shifted the focus from a person centred
approach where errors are viewed as occurring as the
result of the individual, to developing a systems
approach whereby individual error is accepted and
mechanisms are put in place to ensure that error is
reduced in the environment in which it occurs [3,4].
There is an increasing international drive to involve
patients in safety initiatives [5]. However recent reviews
of the literature have highlighted: a lack of initiatives to
promote patient and/or carer involvement in patient
safety; major gaps in our knowledge about the nature
and impact of patient involvement; little evidence of the
feasibility or effectiveness of patient centred interven-
tions and uncertainty over their acceptability amongst
patients and health professionals [5,6]. One role for
patients in improving patient safety is in teaching health
professionals as part of educational interventions.
Patient-led teaching for healthcare professionals
has been reported to be effective in terms of learner
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as communication skills [7]. Patient narratives involving
patients sharing their stories with professionals are now
widely employed as part of medical training and clinical
skills acquisition [7,8]. Patient safety is a particularly
appropriate topic for such teaching as patients can bring
real lived experiences of error and harm to the class-
room, describe the personal impact of such errors and
facilitate discussion around the error. There is a paucity
of research which examines the use of patient stories in
a safety context; although preliminary research suggests
that this is a feasible method for communicating con-
cerns about patient safety to healthcare professionals
[6]. The present study aims to develop an intervention
based on patients as teachers in training junior doctors
about patient safety and to evaluate the impact of this
intervention on safety attitudes in a randomised con-
trolled trial.
Method
Design
The study is a randomised controlled trial conducted in
the North of England with a two step approach covering
West and North/East Yorkshire.
Setting
The study will be conducted in two postgraduate med-
ical schools in the Yorkshire and Humber region,
West Yorkshire (WY) and North East Yorkshire and
North Lincolnshire (NEYNL). In West Yorkshire,
teaching on patient safety takes place at two sites; in
the trial one site will receive the intervention (Harro-
gate Hospital) and a second site will receive the con-
trol (Airedale Hospital). In NEYNL, teaching takes
place at five sites (Scunthorpe, Scarborough, Hull,
Grimsby and York Hospitals). There are ten teaching
sessions in total with each of the hospitals being
responsible for delivering some of the patient safety
teaching. There is variation in the number of sessions
provided at each site, e.g. Grimsby, n = 1; York, n = 3.
Teaching at these sites commences in January 2011
for approximately 8 weeks. The first phase of the
study in the West Yorkshire Foundation School will
allow for the refinement of our methodology and
serve as a trial for our outcome measures. In NEYNL
Foundation School, the intervention and control arm
will run in parallel sessions, trainees and participants
will be randomly assigned to either group on the day
of teaching.
Context
The intervention will be incorporated into the manda-
tory training of the first year postgraduate training for
patient safety, i.e. Foundation Year 1 (FY1) trainees.
Sample
Two separate populations will be recruited a) patients
and b) trainee doctors
a) Patients
Two types of patients will be recruited and will receive
training to deliver the intervention. Firstly patient safety
champions will be identified through a national network
(National Patient Safety Agency (NPSA) and Action
against Medical Accidents (AVMA)). This network of
trained volunteers provides advocates of patient safety
and a source of stories about the personal impact of
error in diagnosis, treatment and care. Secondly, local
patients will be identified from patient and public invol-
vement contacts and existing patient safety research net-
works. There are 16 teaching sessions that require
patient input. We therefore anticipate recruiting
4-5 local patient safety champions and 4-5 national
patient champions to deliver this teaching in both
regions. This will mean that each patient is not overbur-
dened with the number of sessions they deliver or the
time and travel required participating in the study.
b) Trainee doctors
In West Yorkshire there are currently 290 FY1 trainees
enrolled. Eleven teaching sessions are conducted with
approximately 26 trainees attending each session (inter-
vention or control). In NEYNL, approximately 150 trai-
nees will be enrolled as FY1. Ten teaching sessions on
patient safety are conducted; therefore approximately
15 trainees attend each session (Figure 1). Each session
will be equally divided, with approximately 7-8 trainees
receiving the control and 7-8 receiving the intervention,
as illustrated with Scarborough in Figure 1.
Sample Size calculation
In NEYNL, there are 150 trainees that will be allocated
into 20 groups of 7-8 trainees. Assuming an intracluster
 
West Yorkshire: n=290 trainees 
Harrogate – intervention group  Airedale – control group 
NEYNL: n=150 trainees 
Hull  Grimsby  York  Scarborough  Scunthorpe 
Intervention  
n=7-8 
Control 
n=7-8 
26  26  26  26  26  26  26  26  26  26 
15 
15  15 
15 
26 
15  15  15  15  15  15 
Figure 1 Approximate number of participants assigned to
each site.
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of 1.3. The effective sample size, therefore, is 150/1.3,
which is 115. This gives us approximately 80% power to
demonstrate an effect size of 0.53.
Ethical Approval
Ethical approval for the study was granted by the
National Research Ethics Committee in February 2010.
Procedure
Trainees in the control group will be informed that their
course is being evaluated and they will be asked to com-
plete questionnaires during their training. Trainees in
the intervention group will receive the same informa-
tion, and in addition, they will be informed that their
teaching will consist of patients delivering stories about
their experience of a safety incident. Using the patient
experience is an established part of medical teaching
and it is not anticipated that trainees will refuse to be
taught in this manner. Those who do not wish to take
part in either the control or intervention group will not
be asked to complete questionnaires.
Participants in West Yorkshire will consent to the
study at the beginning of the teaching session. At the
intervention site (Harrogate) teaching will be delivered
in the morning session (approximately three hours of
teaching). Two patient champions will speak about their
experiences which will be based around the three
themes covered in the control group, namely, prescrib-
ing, teamwork and effective communication. The con-
trol group (Airedale) will receive three sessions also on
these topics, communicated using the standard methods
of teaching, which includes PowerPoint presentations
and small group work. In the afternoon, at both sites, all
trainees will receive training on: Personal organisation,
Handover, Prioritisation and Transfusion. Question-
naires will be completed before the intervention and
returned on the day of teaching; participants will also be
required to complete the questionnaires at the end of
the teaching session and one month later.
Trainees in NEYNL will be consented on the day of
the study. Any trainees objecting to taking part in the
intervention will be assigned to the control group,
which will run in parallel to the intervention. The con-
trol will receive the standard teaching and the interven-
tion will receive the intervention. These sessions will
run simultaneously.
Development of the intervention
All patient participants identified as potentially suitable
for the study, will receive a letter of introduction, a
study information sheet and provide written consent to
participate in the research. Those who express an inter-
est in the study will be invited to attend an open day
where they can learn more about the research and
decide whether or not they would like to take part. Pre-
paratory patient learning journey (PLJ) workshops will
be held for all patients participating in the training pro-
gramme. These will be facilitated by members of the
‘patient voice’ group at the University of Leeds. These
facilitators, who are patients and carers themselves, help
to create a supportive learning environment where the
patients feel comfortable about sharing their experiences
and valued for their contribution. The approach focuses
on three sessions:
a) The first session is on the ‘patient journey’ in which
the patients are given the opportunity to think and talk
about their own journey and share their experiences.
This session particularly focuses on key contributory
factors for safety such as hygiene, communication, medi-
cations and observations.
b) The second session allows patients to reflect on the
content of the first session and discuss how things could
have been done differently to improve their experiences
with healthcare.
c) The third session builds on the first two sessions to
allow patients to think about how their experiences and
knowledge can help health professionals to learn and
develop their own practice. In addition, it focuses on
how these patients could be involved in teaching health-
care professionals. At the end of these sessions patients
will have developed their experiences into a story of
approximately 20 minutes in length that they will relay
to trainees in the teaching session. The precise content
of the talk is discussed within the patient voice group,
but is largely decided upon by the patients themselves,
e.g. the patients may choose to focus on one particular
aspect of their experience, or supplement their talk with
a PowerPoint presentation to clarify their message. To
ensure patients are fully supported and feel confident
they will be briefed before and after the teaching ses-
sions. A third patient participant will also attend each
teaching session to take observational notes and serve as
a reserve, in case one of the patients is unable to attend.
Intervention
The teaching session will use patient stories to focus
both on the specific issues around the individual patient
story as well as more generic issues around patient
safety. Emphasis will be given to issues of analysis and
causes of errors. The stories will include factual descrip-
tions of what happened and reflections about their
experience with medical error, what went wrong, why it
took place, what the NHS response was, the impact of
the error, the information they were given, what could
be done better and why. The sessions will be interactive
with questions and debate. Facilitation will be provided
by a trained independent chairperson along with the
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patients’ narrative, to identify key themes on patient
safety emerging from the stories and to explore their
own attitudes and beliefs towards patient safety. They
will also be encouraged to share their own experiences
of safety incidents, both as professionals and as patients
or carers themselves.
Measures
Measuring error is difficult [9]. It would be unrealistic
to expect be able to detect or attribute changes in
patient safety incident rates, for example through case
note review, for junior doctor’s practice as part of their
multidisciplinary team. The primary aim of the patient-
led teaching module is to facilitate awareness of patient
safety issues, allow reflection on and facilitate changes
to their attitudes to patient safety and above all, pro-
mote a safety culture among doctors at such an early
stage of their training. It is hoped that this will translate
into improved safety in practice.
Outcome measures for the study will combine quanti-
tative and qualitative methods and include:
1. The Attitudes to Patient Safety Questionnaire
(APSQ) [10], a reliable and validated 26-item ques-
tionnaire addressing patient safety attitudes. It was
originally designed to target senior medical trainees
which make it applicable to FY1 trainees at the start
of their clinical practice.
2. Knowledge of patient safety will be measured
using a reliable and validated 7 item measure specifi-
cally designed to target medical trainees [11]. Both
measures will be administered to all trainees in both
the intervention and control groups before and after
the training session and 4-6 weeks later.
3. All trainees will be asked to complete a course
evaluation at the end of the teaching session to
assess overall effectiveness.
4. Twenty in depth interviews with a purposive sam-
ple of ten trainees from each group (control/inter-
vention) will explore their views on the impact of
medical error on patient outcome and the perceived
usefulness and acceptability of the two training ses-
sions. These will be conducted 4-6 weeks after the
teaching session. Feedback from patients and experts
suggests that patient stories provoke an emotional
response in the learner. Trainees will be specifically
asked about any psychological impact of the patient
narratives on themselves with the intention of devel-
oping a measure to examine learning. Any differ-
ences in views on the perceived value and
effectiveness of the two teaching sessions will be
evaluated. The patients involved in the training will
also be interviewed individually to explore their
views on how effective the teaching programme was,
how it had helped them understand the health sys-
tem and reasons for medical errors. Transcripts will
be content-analysed using thematic framework ana-
lysis. A constant comparative approach to the analy-
sis of qualitative data will be used.
5. Observational notes will be taken by a third
patient participant. The notes will focus on signs of
audience engagement, levels of interest such as non
verbal cues.
6. Trainees will be asked to identify up to 3 learning
points that they identify at the end of the teaching
session, that they intend to implement into practice.
Trainees will be followed up at one month to
s e ew h e t h e ro rn o tt h e yh a v eb e e ns u c c e s s f u li n
doing so.
Analysis
We will undertake a regression based analysis adjusting
for any clustering effects using the Huber-White
approach as implemented in STATA. We will adjust for
baseline test scores.
Discussion
The strength of this research is our commitment to
patient involvement. The patients in our study will not
only deliver the intervention, but will be involved in
defining the aims and objectives of the teaching ses-
sions, provide feedback on documents, e.g. our interview
guide for trainee doctors; and will take part in focus
groups after the teaching sessions to refine the interven-
tion. This will require considerable commitment from
the patient and in recognition of their contribution they
will be provided with financial reimbursement for their
attendance on the teaching and training days, in addi-
tion to travel expenses.
This research also poses a number of challenges.
Firstly, patient safety teaching is already established in
both West Yorkshire and NEYNL. The research team
must therefore negotiate the integration of the study
into the existing teaching curriculum. This requires
careful consideration of pre-existing learning outcomes
to ensure that the teaching fulfils the Foundation
School’s obligation to provide comprehensive safety
training. The research team must also work closely with
Foundation Year 1 co-ordinators and facilitators to
ensure successful implementation of the study. Secondly,
t h e r ei sl i t t l ee v i d e n c eo fo ptimal objective outcome
measures for educational interventions, particularly in
the medium or long term. There is also a lack of con-
sensus as to whether attitudes can be changed and
whether these changes will necessarily translate into
professional behaviour. To address this challenge we
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interviews, focus groups and self reported learning to
provide a richness of data.
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